We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$89.6B
AUM Growth
-$307M
(-0.34%)
Cap. Flow
-$521M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
13.13%
Holding
1,015
New
93
Increased
423
Reduced
329
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$536M |
| 2 |
WPZ
Williams Partners L.P.
WPZ
|
+$409M |
| 3 |
PepsiCo
PEP
|
+$325M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$220M |
| 5 |
PG&E
PCG
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Petrobras Class A
PBR.A
|
+$417M |
| 2 |
WPZ
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
|
+$383M |
| 3 |
AGN
Allergan Inc
AGN
|
+$340M |
| 4 |
AbbVie
ABBV
|
+$257M |
| 5 |
Exelon
EXC
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 17.02% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 12.41% |
| 4 | Communication Services | 11.87% |
| 5 | Consumer Discretionary | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QGENF
626
DELISTED
QIAGEN NV
QGENF
| $17M | 0.02% |
672,970
| – | – |
|
|
RIOM
627
DELISTED
RIO ALTO MNG LTD NEW COM SHS (CANADA)
RIOM
| $16.9M | 0.02% |
+6,850,000
| New | +$19M |
|
628
Madison Square Garden
MSGS
$9.56B
| $16.9M | 0.02% |
279,368
-247,874
| -47% | -$13.6M |
|
|
PBFX
629
DELISTED
PBF LOGISTICS LP
PBFX
| $16.8M | 0.02% |
741,570
| – | – |
|
630
Integer Holdings
ITGR
$3.39B
| $16.7M | 0.02% |
317,320
+8,137
| +3% | +$386K |
|
|
LOCK
631
DELISTED
LifeLock, Inc.
LOCK
| $16.7M | 0.02% |
1,181,528
-1,244,190
| -51% | -$17.8M |
|
632
West Pharmaceutical
WST
$23.5B
| $16.5M | 0.02% |
274,475
-171,980
| -39% | -$9.17M |
|
|
CXO
633
DELISTED
CONCHO RESOURCES INC.
CXO
| $16.5M | 0.02% |
142,060
+79,410
| +127% | +$8.65M |
|
|
CYT
634
DELISTED
CYTEC INDS INC
CYT
| $16.3M | 0.02% |
301,940
+8,081
| +3% | +$403K |
|
635
Monster Beverage
MNST
$93B
| $16.2M | 0.02% |
+701,280
| New | +$14.7M |
|
636
Electronic Arts
EA
$52.4B
| $16.1M | 0.02% |
273,620
+81,440
| +42% | +$4.39M |
|
|
FISV
637
Fiserv Inc
FISV
$27.8B
| $16.1M | 0.02% |
405,300
+79,220
| +24% | +$3.02M |
|
|
FNFG
638
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $16M | 0.02% |
1,814,549
-1,075,088
| -37% | -$9.17M |
|
639
Celanese
CE
$4.95B
| $16M | 0.02% |
286,115
+83,830
| +41% | +$4.75M |
|
640
Methanex
MEOH
$4.17B
| $16M | 0.02% |
297,875
+1,480
| +0.5% | +$74.2K |
|
641
Albany International
AIN
$2.16B
| $15.9M | 0.02% |
400,000
| – | – |
|
|
CERN
642
DELISTED
Cerner Corp
CERN
| $15.8M | 0.02% |
215,720
+10,940
| +5% | +$757K |
|
|
ISCA
643
DELISTED
International Speedway Corp
ISCA
| $15.6M | 0.02% |
479,226
+11,053
| +2% | +$344K |
|
|
REGI
644
DELISTED
Renewable Energy Group, Inc.
REGI
| $15.6M | 0.02% |
1,690,779
+32,012
| +2% | +$292K |
|
|
MJN
645
DELISTED
Mead Johnson Nutrition Company
MJN
| $15.5M | 0.02% |
154,350
+7,830
| +5% | +$790K |
|
646
TransDigm Group
TDG
$71.5B
| $15.4M | 0.02% |
+70,520
| New | +$14.9M |
|
647
Booz Allen Hamilton
BAH
$8.72B
| $15.4M | 0.02% |
532,622
+7,228
| +1% | +$210K |
|
648
Tronox
TROX
$976M
| $15.4M | 0.02% |
757,669
+14,371
| +2% | +$306K |
|
|
ARIA
649
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $15.3M | 0.02% |
1,852,920
+232,360
| +14% | +$1.72M |
|
650
Universal Corp
UVV
$1.34B
| $15.2M | 0.02% |
+323,275
| New | +$14.3M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2015 Portfolio in Review
As of Q1 2015, OppenheimerFunds held 1,015 positions worth $89.6B, down 0.34% from $89.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
OppenheimerFunds's Q1 2015 filing shows 93 new, 423 increased, 329 reduced and 118 closed positions. Its largest new stake was UBS Group: 30,806,912 shares worth $578M. The largest sale was Petrobras Class A, an estimated $417M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q1 2015 buy was UBS Group: 30,806,912 shares worth $578M.
- OppenheimerFunds added most to Williams Partners L.P. in Q1 2015, an estimated $409M increase.
- OppenheimerFunds's biggest Q1 2015 reduction was AbbVie, cutting an estimated $257M.
- OppenheimerFunds fully exited Petrobras Class A in Q1 2015, selling an estimated $417M.
- OppenheimerFunds's ten largest holdings make up 13% of its $89.6B portfolio in Q1 2015.
- OppenheimerFunds opened 93 new positions and closed 118 in Q1 2015.
- OppenheimerFunds's portfolio value fell 0.34% quarter-over-quarter to $89.6B.
Based on OppenheimerFunds's 13F filing for Q1 2015, filed 15 May 2015.